In-Depth Research On:
Orexigen Therapeutics, Inc. (OREX)

Sign Up Now to Download a Free Research Report on OREX

Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts

Select your areas of interest / would you like to receive the newsletter?




Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader.

Orexigen Therapeutics, Inc.

Orexigen Therapeutics shares gained 3.08 percent to close at $5.85 a share Friday. The stock traded between $5.60 and $5.93 on volume 4.86 million shares traded. Last week, the company announced that the FDA has extended the Prescription Drug User Fee Act (PDUFA) action date for NB32 to September 11, 2014. Shares of Orexigen Therapeutics are up approximately 4.0 percent year-to-date.

Going forward ... (see research report)


RESEARCH REPORT ON OREX
Download Free Report Now


Preview Pages of Actual Research Report

Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader. Research Report on    Research Report on    Research Report on    

Research Report on    Research Report on    Research Report on